MedTrace Logo

New Treatments for Actinic Keratoses of the Scalp

NCT05456334 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-11-21

No results posted yet for this study

Summary

This blinded controlled 2-year study on 120 patients with 2 or more actinic keratoses, compare the efficacy and tolerability of pulsed dye-laser- mediated photodynamic therapy compared to conventional photodynamic therapy and fractional-laser assisted daylight photodynamic therapy compared to daylight photodynamic therapy.

Conditions

  • Photodamaged Skin
  • Actinic Keratoses

Interventions

DEVICE

Pulsed-dye laser

Comparance of pulsed-dye laser-mediated and conventional photodynamic therapy in a split-head design

DEVICE

Fractional CO2-laser

Comparance of fractional CO2-laser-mediated or plain daylight photodynamic therapy in a split-head design

DRUG

Metvix cream

Metvix-cream was used for photodynamic therapy in all experimental arms

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-24
Primary Completion
2023-12-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05456334 on ClinicalTrials.gov